Bank of America to Spend $250 Million Annually on GLP-1 Drugs
Bank of America plans to spend $250 million a year on GLP-1 medicines, NDTV Profit reports. The drugs include Ozempic and Wegovy, which have seen rising demand. Each patient’s treatment can cost…
